Gilead Sciences’ Johanna Mercier sells 28,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences, Inc. Chief Comm & Corp Aff Officer Johanna Mercier exercised options on November 16, 2026, to acquire 25,000 common shares at $72.34 and sold 28,000 shares in three reported transactions that day. Sale prices ranged from $169.57 to $170.56 for 13,922 shares, $170.58 to $171.53 for 13,178 shares, and $171.65 to $171.69 for 900 shares. The transactions were made under a Rule 10b5-1 trading plan adopted February 20, 2025. Following the option transaction, her reported option position was 44,960 options. The options have a four-year vesting schedule: 25% vest on the grant’s first anniversary, with the balance vesting 6.25% quarterly thereafter until fully vested.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (Right to Buy) F1, F5 | 25,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 25,000 | $72.34 | $1.81M |
| Sale | Common Stock F1, F2 | 13,922 | $169.9711 | $2.37M |
| Sale | Common Stock F1, F3 | 13,178 | $171.0937 | $2.25M |
| Sale | Common Stock F1, F4 | 900 | $171.6856 | $155K |
Footnotes (5)
- F1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- F2. Sale prices for the transactions reported range from $169.57 to $170.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F3. Sale prices for the transactions reported range from $170.58 to $171.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F4. Sale prices for the transactions reported range from $171.65 to $171.69. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F5. The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Key Figures
Key Terms
Non-qualified Stock Option (Right to Buy) financial
Rule 10b5-1 trading plan regulatory
four-year vesting schedule financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.